Name | 4-Chloro-1,5-naphthyridine |
---|---|
Synonyms |
4-chloro-[1,5]naphthyridine
1,5-Naphthyridine, 4-chloro- 4-chloranyl-1,5-naphthyridine 4-Chloro-1,5-naphthyridine 4-Chlor-1,5-naphtyridin 8-chloro-1,5-naphthyridine 4-Chlor-1,5-naphthyridin |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 269.2±20.0 °C at 760 mmHg |
Melting Point | 102-103ºC |
Molecular Formula | C8H5ClN2 |
Molecular Weight | 164.592 |
Flash Point | 142.5±7.4 °C |
Exact Mass | 164.014130 |
PSA | 25.78000 |
LogP | 0.89 |
Vapour Pressure | 0.0±0.5 mmHg at 25°C |
Index of Refraction | 1.663 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933990090 |
~61% 7689-63-6 |
Literature: Sieb, David; Schuhen, Katrin; Morgen, Michael; Herrmann, Heike; Wadepohl, Hubert; Lucas, Nigel T.; Baker, Robert W.; Enders, Markus Organometallics, 2012 , vol. 31, # 1 p. 356 - 364 |
~40% 7689-63-6 |
Literature: Nishimura, Nobuko; Siegmund, Aaron; Liu, Longbin; Yang, Kevin; Bryan, Marian C.; Andrews, Kristin L.; Bo, Yunxin; Booker, Shon K.; Caenepeel, Sean; Freeman, Daniel; Liao, Hongyu; McCarter, John; Mullady, Erin L.; San Miguel, Tisha; Subramanian, Raju; Tamayo, Nuria; Wang, Ling; Whittington, Douglas A.; Zalameda, Leeanne; Zhang, Nancy; Hughes, Paul E.; Norman, Mark H. Journal of Medicinal Chemistry, 2011 , vol. 54, # 13 p. 4735 - 4751 |
~% 7689-63-6 |
Literature: Adams et al. Journal of the American Chemical Society, 1946 , vol. 68, p. 1317 |
~36% 7689-63-6 |
Literature: VIFOR (INTERNATIONAL) AG Patent: US2012/214803 A1, 2012 ; Location in patent: Page/Page column 174 ; US 20120214803 A1 |
~% 7689-63-6 |
Literature: VIFOR (INTERNATIONAL) AG Patent: US2012/214803 A1, 2012 ; US 20120214803 A1 |
~% 7689-63-6 |
Literature: Nishimura, Nobuko; Siegmund, Aaron; Liu, Longbin; Yang, Kevin; Bryan, Marian C.; Andrews, Kristin L.; Bo, Yunxin; Booker, Shon K.; Caenepeel, Sean; Freeman, Daniel; Liao, Hongyu; McCarter, John; Mullady, Erin L.; San Miguel, Tisha; Subramanian, Raju; Tamayo, Nuria; Wang, Ling; Whittington, Douglas A.; Zalameda, Leeanne; Zhang, Nancy; Hughes, Paul E.; Norman, Mark H. Journal of Medicinal Chemistry, 2011 , vol. 54, # 13 p. 4735 - 4751 |
~% 7689-63-6 |
Literature: INFINITY PHARMACEUTICALS INC.; INTELLIKINE, LLC; CASTRO, Alfredo, C.; EVANS, Catherine, A.; JANARDANANNAIR, Somarajannair; LESCARBEAU, Andre; LIU, Tao; SNYDER, Daniel, A.; TREMBLAY, Martin, R.; REN, Pingda; LIU, Yi; LI, Liansheng; CHAN, Katrina Patent: WO2013/12915 A1, 2013 ; WO 2013/012915 A1 |
~% 7689-63-6 |
Literature: INFINITY PHARMACEUTICALS INC.; INTELLIKINE, LLC; CASTRO, Alfredo, C.; EVANS, Catherine, A.; JANARDANANNAIR, Somarajannair; LESCARBEAU, Andre; LIU, Tao; SNYDER, Daniel, A.; TREMBLAY, Martin, R.; REN, Pingda; LIU, Yi; LI, Liansheng; CHAN, Katrina Patent: WO2013/12915 A1, 2013 ; WO 2013/012915 A1 |
Precursor 5 | |
---|---|
DownStream 3 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |